Generics industry pressures FDA over biosimilar naming standards - PMLiVE

20-09-2013 PMLiVEComments (0)


All biosimilar products marketed in the US should share the same non-proprietary name as the branded biologic medicines they are copies of, according to the country's generics industry. Trade body the Generic Pharmaceutical Association (GPhA) has filed ...

Read more on PMLiVE

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top